Which imaging modality is most sensitive for detecting small liver lesions after hepatobiliary contrast administration?

Which imaging modality is most sensitive for detecting small liver lesions after hepatobiliary contrast administration?

• A. MRI.
• B. CT.
• C. Ultrasound.
• D. PET/CT.

Answer: (A)

Hepatobiliary contrast-enhanced MRI is most sensitive for spotting small liver lesions because the contrast agent is taken up by functioning hepatocytes and excreted into bile. In the hepatocyte phase, the normal liver parenchyma becomes bright, while lesions that lack normal hepatocytes or have disrupted biliary uptake (such as many metastases or some hepatocellular carcinomas) remain relatively dark. This creates a high contrast between lesion and background liver, making even tiny foci stand out. Beyond this contrast boost, MRI provides excellent soft-tissue resolution and functional information. Sequences like diffusion-weighted imaging add sensitivity by highlighting lesions with restricted diffusion, and the full multiphase dynamic imaging (arterial, portal venous, and hepatobiliary phases) helps characterize lesions more accurately than other modalities. CT, ultrasound, and PET/CT lack this combination of hepatocyte-specific uptake and high-resolution liver imaging. CT and ultrasound have limited contrast between small lesions and normal liver tissue, and PET/CT depends on metabolic activity that may be absent or equivocal in small or certain tumor types, reducing sensitivity for small lesions.

Hepatobiliary contrast-enhanced MRI is most sensitive for spotting small liver lesions because the contrast agent is taken up by functioning hepatocytes and excreted into bile. In the hepatocyte phase, the normal liver parenchyma becomes bright, while lesions that lack normal hepatocytes or have disrupted biliary uptake (such as many metastases or some hepatocellular carcinomas) remain relatively dark. This creates a high contrast between lesion and background liver, making even tiny foci stand out.

Beyond this contrast boost, MRI provides excellent soft-tissue resolution and functional information. Sequences like diffusion-weighted imaging add sensitivity by highlighting lesions with restricted diffusion, and the full multiphase dynamic imaging (arterial, portal venous, and hepatobiliary phases) helps characterize lesions more accurately than other modalities.

CT, ultrasound, and PET/CT lack this combination of hepatocyte-specific uptake and high-resolution liver imaging. CT and ultrasound have limited contrast between small lesions and normal liver tissue, and PET/CT depends on metabolic activity that may be absent or equivocal in small or certain tumor types, reducing sensitivity for small lesions.